+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06975072

Study of Magnesium Sulfate Effects on Neuromonitoring During Spinal Fusion Surgery

Led by University of California, San Francisco · Updated on 2026-08-21

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Spinal surgeries are becoming more frequent and complex, carrying risks of injury to neural structures. Intraoperative neurophysiologic monitoring IONM helps detect changes in motor and sensory pathways during surgery to improve safety. This trial evaluates how magnesium, a commonly used anesthetic adjunct to reduce pain and opioid use, affects Transcranial Motor Evoked Potentials TcMEPs, which monitor motor pathway integrity during spinal surgery. Despite widespread use, there is limited clinical data on magnesiums impact on these neuromonitoring signals. Participants will undergo standard general anesthesia with propofol and remifentanil, and all will have neuromonitoring equipment placed as usual. The experimental group receives a single intravenous bolus of magnesium sulfate at 30 mgkg over 10 minutes, while the control group follows the same protocol without magnesium. Blood samples will be collected at multiple time points up to 12 hours after magnesium administration to measure plasma levels and pharmacokinetics. The study aims to establish a protocol to quantify magnesiums effects on TcMEPs, providing data to guide safer anesthetic adjunct use. During surgery, baseline motor-evoked potential data will be collected, followed by magnesium administration in the experimental group. Researchers will monitor neuromonitoring data, including stimulation voltage, MEP amplitude, and latency, throughout the procedure. Blood tests for magnesium levels will be performed at scheduled intervals. Participants are adults undergoing elective thoracolumbar fusion with planned neuromonitoring. The study does not extend anesthesia time or add extra monitoring procedures beyond standard care. Outcome measures include magnesium pharmacokinetics and neuromonitoring changes over about one year of study completion.

CONDITIONS

Brief Title

Effect of Magnesium on Neuromonitoring

Research Team

H

Hemra Cil, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here